Epidermolysis bullosa simplex (EBS) arises from mutations within the keratin 5 and 14 (K5 and K14) genes which alter the integrity of basal keratinocytes cytoskeleton. The majority of these defects are missense mutations in the rod domain, whose locations influence the disease severity. We investigated a large family dominantly affected with the Dowling-Meara form of EBS (EBS-DM). Sequencing of amplified and cloned K5 cDNA from cultured keratinocytes revealed a 66 nucleotide deletion in one allele corresponding to the last 22 amino acid residues encoded by exon 1 (Val164 to Lys185). Sequencing of amplified genomic DNA spanning the mutant region revealed a heterozygous G-to-A transition at + 1 position of the consensus GT donor splice site of intron 1 of K5. This mutation leads to the use of an exonic GT cryptic donor splice site, located 66 nucleotides upstream from the normal donor splice site of intron 1. The corresponding peptide deletion includes the last five amino acids of the H1 head domain and the first 17 amino acids of the conserved amino terminal end of the 1A rod domain, including the first two heptad repeats and the helix initiation peptide. The shortened polypeptide is expressed in cultured keratinocytes at levels which are comparable to the normal K5 protein. This is the first splice site mutation to be reported as a cause of EBS-DM. Owing to the functional importance of the removed region, our data strongly suggest that shortened keratin polypeptide can impair keratin filament assembly in a dominant manner and causes EBS-DM.
Introduction
Epidermolysis bullosa simplex (EBS) comprises a group of hereditary skin diseases characterised by blistering of the skin following mild physical trauma as a result of cytolysis within the basal epidermal cells. 1, 2 EBS is commonly inherited in an autosomal dominant fashion with an incidence of 1 in 50 000. Three major different subtypes are recognised. The Dowling-Meara form of EBS (EBS-DM) is the most severe type where blistering can be generalised, occurs in clusters, is often associated with hyperkeratosis of palms and/or soles and is distinguished from other forms by clumping of keratin filaments in the basal epidermal cells. The Koebner type (EBS-KS) shows milder generalised blistering, whereas the Weber-Cockayne form (EBS-WC) is the mildest form of EBS, with blistering confined to the hands and feet.
Studies of transgenic mice expressing mutant keratins, together with linkage and mutation analyses in EBS patients and in vitro point mutagenesis studies have established that defects in either of the genes encoding the basal epidermal keratins K5 and K14 underlie most EBS cases. [3] [4] [5] [6] [7] [8] EBS mutations are most often missense mutations located within the central helical rod domain of K5 or K14. The precise location of the amino acid changes within the keratin molecules correlates with the degree to which they impair keratin filament assembly and with disease severity. 9, 10 Specifically, EBS-DM mutations occur within the highly conserved α-helical end segments of helix 1A and 2B and induce major defects in keratin filament elongation. 4, 6, [11] [12] [13] [14] [15] [16] In particular, R125C and R125H mutations in K14 account for the majority of EBS-DM cases. 10, 11 Mutations in EBS-K are more internal to the α-helical rod domain, 5, [17] [18] [19] [20] whereas mutations in EBS-WC have been found in the non-helical linker (L1-2) region of K5 and K14, and in the H1 head domain of K5. 12, [21] [22] [23] [24] [25] [26] Recently, a missense mutation in the non-helical V1 head domain of K5 was identified in patients with EBS with mottled pigmentation. 27, 28 We investigated a multigenerational family dominantly affected with EBS-DM for mutations in K5 cDNA. We describe abnormal splicing of the last 66 nucleotides in exon 1 caused by a genomic mutation at the consensus donor splice site of intron 1. We show that this mutation co-segregates with the disease in this family and results in the synthesis of a shortened polypeptide lacking important functional domains of K5.
Materials and Methods

Clinical Description
We studied a family of French ancestry, with a threegeneration history of blistering disease affecting eleven members in an autosomal fashion with complete penetrance (Figure 1 ). All affected individuals suffered since birth from recurrent and general blistering after mild physic trauma. Nonscarring blistering occurs at any body site, often in clusters, predominantly on hands, elbows, feet, knees and the face. Oral blistering was sometimes noted. Disease exacerbation was observed during the summer. Moderate hyperkeratosis of palms and soles was present in several affected individuals. No milia were noted, and hair, nails and teeth were normal. Electron microscopic examination of a skin biopsy obtained after rubbing an intact area showed cleavage within the basal keratinocytes with clumping of keratin filaments. The basement membrane zone, hemidesmosomes and anchoring fibrils were normal. The overall presentation was very suggestive of the Dowling-Meara form of EBS.
Keratinocyte Culture, RNA Extraction and Reserve Transcriptase-PCR
Keratinocytes were cultured from 5-mm punch biopsies obtained from patient II-4 as described by Rheinwald and Green. 29 Total RNA was extracted from confluent cell layers using the guanidium thiocyanate method described by Chomczynski and Sacchi. 30 After reverse transcription using random hexanucleotides (Pharmacia, St Albans, UK) and Moloney murine leukaemia virus reverse transcriptase (Statagene, Cambridge, UK), cDNA was used as a template in a 50 µl PCR mixture containing 10 picomoles of each specific K5 primer, 200 µM dNTPs, 1 ϫ PCR buffer with 1.5 mM MgCl 2 and one unit of AmpliTaq DNA polymerase (Perkin Elmer, Warrington, UK). The coding sequence of keratin 5 cDNA was amplified using overlapping sets of primers:
5'-AGCAGCTTGCGGTAAGTGG-3' for exons 5-7 and K5F1711 5'-GAAGGCCAAGCAGGA-CATG-3'/K5R2123 5'-CAAATTTGACGCTGGAGCTG-3' for exon 8. Primers are numbered according to GenBank accession number M21389. Thirty-five cycles of PCR were performed at the following conditions: 94°C for 30 s, 55°C for 45 s, 72°C for 10 s. An aliquot of the PCR products was run on 6% acrylamide gels before sequencing and stained with ethidium bromide.
PCR-amplification of Genomic DNA Genomic DNA was extracted from peripheral leukocytes and was used as a template for PCR amplification. The genomic region of K5 spanning the donor splice site of exon 1 was amplified using primers K5F649 and K5R1080. 
Sequencing of PCR Products
Amplified material was sequenced directly or was cloned into the pGEM-T cloning vector (Promega) prior to sequencing, according to manufacturer's instructions. Sequencing was performed in both directions by the dideoxy-nucleotide method using Sequenase version 2.0 (United States Biochemical, Cleveland, USA) using vector primers T3 and T7 and insert-specific primers for sequencing reactions. The donor splice site mutation was identified by sequencing and confirmed by HphI restriction enzyme digestion (New England Biolabs, Hitchin, UK).
Immunoblotting The cytokeratins were extracted and analysed by SDS-polyacrylamide gel electrophoresis followed by immunoblotting as previously described. 31 Antibodies to keratin 5 tested were BL18, a rabbit polyclonal raised against the last nine residues of K5 (TSSSRKSFK), 32 and RCK102, a mouse monoclonal antibody specific for K5 and K8. 33 The secondary antibodies were goat anti-rabbit or rabbit antimouse IgG conjugated to alkaline phosphatase (Dako, Bucks, UK). The blots were scanned on a 'Bio Image Whole Band Analyzer' to determine the relative proportions of the normal and mutant keratin 5 bands.
Results
Mutation Analysis
Overlapping regions of keratin 5 cDNA were amplified by reverse transcriptase polymerase chain reaction (RT-PCR) of keratinocyte RNA from patient II-4 and were analysed on 6% acrylamide gels prior to sequence analysis. Products obtained with primers K5F649 and K5R1080 revealed a shorter band and two heteroduplexes in addition to the band of normal size seen in control keratinocytes ( Figure 2 ). Cloning and sequencing of these PCR products showed the in-frame removal in several clones of the last 66 nucleotides (881 to 946) encoding Val164 to Lys185 from exon 1, and normal sequence in other clones (Figure 3a) . No other aberrant K5 cDNA sequence could be detected.
To identify the keratin 5 gene defect underlying this change, genomic DNA spanning exon 1 and its flanking donor-splice site, was PCR-amplified from patient peripheral lymphocytes using primers K5F649 and K5R1080. Analysis of the PCR-amplified products on a 6% acrylamide gel showed a band of normal size (1016 bp) and no evidence of a shorter band or heteroduplexes. Cloning and sequencing of these PCR products demonstrated a single base GT-to-AT change in the consensus donor splice site of intron 1 in several genomic clones (Figure 3b ). Other clones from this patient contained the normal sequence. Direct sequencing of PCR-amplified genomic DNA confirmed that the patient was heterozygote for this mutation designated 946 + 1 G→A. This mutation involves the invariant GT donor-splice consensus sequence, suggesting that it would alter splicing of keratin 5 mRNA. In fact, it is likely that this mutation leads to the use of a GTGAG cryptic donor splice site of exon 1, located 66 nucleotides upstream from the normal splice site of intron 1 (Figure 4a ). Abnormal splicing of exon 1 removes the last five amino acids of the H1 head domain and 17 amino acids of the 1A rod domain of K5, including the first two heptad repeats (Figure 4b) .
Screening for the Mutation
The 946 + 1 G→A mutation abolishes a restriction enzyme site for HphI (GGTGA) and yields digestion fragments of 231 and 785 bp from the mutant allele, and 231, 66 and 719 bp from the normal allele. HphI digests of PCR amplified genomic DNA from the patient and six other affected individuals in this family confirmed that they were heterozygotes for this mutation. In contrast, this mutation was not observed in any of the unaffected members of the family tested and was not 
Immunodetection of the Keratin 5 Mutant
Expression of the keratin 5 polypeptide was studied by immunoblotting of protein extracts isolated from culture keratinocytes from the patient and a control ( Figure 5 ). The normal keratinocytes extracts contained a unique K5 peptide of normal size. In contrast, patient extracts showed a smaller band in addition to the peptide of normal electrophoretic migration. Scanning of these signals showed that the intensity of the smaller band was between 66 and 84% of the normal band in the patient extracts, indicating that substantial amounts of the mutant keratin 5 were expressed.
Screening of K5 cDNA for Additional Nucleotide Changes
Further sequencing of the K5 cDNA from patient II-4 showed two nucleotide variations located in the V1 and H1 domains of K5, none of which changed the corresponding encoded amino acids: a previously reported C-to-T transition at the third base of the leucine codon 117 was present on both K5 alleles and a T-to-C transition was identified at the third base of the threonine codon 210 on the normal K5 allele. The previously described G138E polymorphism in the H1 domain of the K5 gene which is known to result in an abnormal migration pattern of the polypeptide variant was not found in our patient. 34 Finally, sequencing of the entire rod domain of K5 did not reveal other 
(a) In the patient, sequencing of clones containing the short RT-PCR product (366 bp) revealed the removal of the last 66 nucleotides of exon 1 (from 881 to 946)(arrowhead) of K5 transcripts. (b) Sequence analysis of cloned PCR products from the patient's amplified genomic DNA showed in several clones, a g-to-a mutation (arrowhead and asterisk) at the consensus gt donor splice site (boxed) of intron 1. Other genomic clones showed a normal sequence. The exon 1 and 2 sequence is indicated by upper case letters, the intron 1 sequence by lower case letters. Numbering of the amino acids and nucleotides refers to the cDNA sequence in GenBank no. M21389.
Splice site mutation in keratin 5 in EBS-DM t nucleotide variation predicting an amino acid change or a splicing abnormality.
Discussion
We describe a family with EBS-DM where affected individuals are heterozygous for a donor splice site mutation of intron 1 of the keratin 5 gene. This mutation results in abnormal splicing of the last 66 nucleotides of exon 1 by activation of a cryptic exonic splice site. The corresponding peptide deletion spans the last 5 amino acids of the H1 head domain and the first 17 amino acids of the 1A rod domain of K5 including the two first heptad repeats. The shortened K5 polypeptide is expressed in amounts which are comparable to the normal K5 protein, suggesting that it retains sufficient integrity to interfere with keratin filament formation and causes EBS-DM in this family.
Donor Splice Site Mutation of Intron 1 Activates a Cryptic Splice Site with High Potential for Splicing
The G-to-A transition that we describe occurs at the + 1 donor splice position of an intron, a position which has been shown to be invariant in almost all examined eukaryotic genes. 35 Examples of mutations at this position causing activation of a cryptic splice site or resulting in exon skipping have been documented in several other disease-causing genes. 36 In the case that we report, mutation of the normal donor splice site of intron 1 results in the use of a cryptic GT splice site of exon 1 which is part of a AGGTGAGG consensus sequence. This sequence is almost identical to the natural occurring donor splice site of intron 1 of keratin 5 (AGgtgagc) and to the consensus sequence (AGgtgagt) found at the 5' end of a majority of eukaryotic introns. 35 We calculated the scores of these splicing sequences as described by Shapiro and Senapathy. 35 We found scores of 90.87 for the normal splice site (AGgtgagc), 72.62 for the mutated splice site (AGatgagc) and 92.15 for the cryptic splice site (AGGTGAGG) within exon 1. These values support the possibility that the mutation of the natural donor splice site of intron 1 has favoured the use of the cryptic splice site of exon 1 with higher statistical score.
Consequences of Abnormal Splicing of Exon 1
Abnormal splicing of exon 1 results in the inframe removal of the last 5 amino acids (VRTEE) of the H1 region, and the first 17 amino acids of the 1A domain including the first two heptad repeats (IKTLNNK-FASFIDK) of K5 (Figure 4b ). These sequences are highly conserved among human type II keratins and intermediate filaments from distant species ( Figure 6 ). Several lines of evidence indicate that they play an important role in keratin filament formation. Specifically, deletion experiments of the head domain of K5, including the H1 sequences immediately adjacent to the start of the rod domain, resulted in alteration of elongation and lateral alignment of keratin filaments in in vitro filament assembly studies. 37 Also, competition experiments with synthetic peptides to the H1 domain of keratin 1 have suggested that the H1 domain in type II keratins is important for stability and alignment of keratin filaments, possibly through interactions with L2 and 2B sequences. 38 These observations indicate that the head of type II keratins, but not of type I keratins (which do not possess a H1 region), is crucial for keratin filament formation. 7, 39 Furthermore, the two first heptad repeats of the 1A domain of K5 are located at the highly conserved amino terminal rod end of the molecule, spanning the LNNKFASFIDK sequence known as the helix initiation peptide (HIP). It is notable that the three other mutations described in the 1A domain of K5 in EBS-DM (L174F, N176S and F179S) [14] [15] and all 16 K14 mutations reported in EBS-DM have been identified within the HIP sequence of these genes. 8 In support of the importance of this region in keratin filament assembly, several deletion and mutagenesis studies have previously provided compelling evidence that defects in this conserved HIP sequence are very disruptive to filament elongation, consistent with the head to tail alignment of keratin heterodimers. [40] [41] [42] For these reasons, we believe that the removal of this sequence from the K5 polypeptide, together with the elimination of the adjacent part of the H1 domain, impairs keratin filament formation and causes EBS-DM.
Proposed Mechanism of Disease
Protein analysis of keratinocyte extracts showed that significant amounts of shortened keratin 5 polypeptide is expressed in vitro, suggesting that the mutated protein retains sufficient structural integrity to interact with its K14 partner and impairs keratin filament formation in a dominant negative manner. During the formation of coiled-coil heterodimers, it is possible that the association of the shortened K5 polypeptide with its K14 partner leaves the first and second heptad repeats of K14 unpaired, whereas the other heptad repeats of both molecules could align normally to establish the largest number of hydrophobic interactions. However, according to the current model for keratin molecule assembly, the absence of H1 and 1A end sequences from K5 is expected to alter both head-to-tail alignment of dimers, whose rod ends have been suggested to overlap slightly during protofilament formation, and lateral association of staggered K5-K14 dimers at the protofilament and protofibril level. 39, 43 Interestingly, despite the fact that keratin aggregates could be seen in basal keratinocytes of skin biopsies from patient II-4, immunofluorescence staining of cultured keratinocytes from the same patient with antibodies BL18 and 14, 15 is underlined.
Splice site mutation in keratin 5 in EBS-DM t RCK102 showed no evidence for filament abnormalities. This result is consistent with the observation that cultured cells from EBS patients have to be stressed before any aggregates can be seen. 44 
Genotype-Phenotype Correlation
This is the first report of a keratin mutation in EBS-DM which is not a straightforward missense mutation. All the previously reported mutations have been within the helix initiation or the helix termination peptide of K5 or K14, mutations in K5 being less frequently reported than K14 mutations (Figure 4b ). In other forms of EBS, two previous keratin non-missense mutations have been described: a three-nucleotide deletion (∆E375K14) was reported in EBS-WC, 24 and a mutation of the acceptor splice site of intron 1 in keratin 14 leading to a premature termination codon and absence of protein expression in a kindred with severe recessive EBS. 45 Other splice-site mutations in keratin genes associated with diseases have not been reported to our knowledge. 8 Despite the large size of the defect, the patients from this family exhibited features which are similar to classical EBS-DM. This is in contrast to a recently reported severe case of EBS-DM caused by a Y129D mutation in the conserved amino-terminal end of helix 1A of keratin 14. 13 This suggests that some missense mutations can be more disruptive on keratin filament formation than in-frame removal of complete sequences from the H1 and 1A domains. Finally, the case that we describe provides new evidence for heterogeneity in the nature of keratin defects underlying EBS and their phenotypic consequences.
